Clinical Trials Browser

Terminated × Uveal Melanoma × 1 year × Clear all

Uveal Melanoma

NCT03865212 2026-01-28

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Phase 1 Terminated

12 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT03746431 2026-01-07

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Phase 1 Terminated

78 enrolled

BreastDermatologicEndocrineGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT04935229 2025-10-22

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Phase 1 Terminated

67 enrolled

Dermatologic

Uveal Melanoma

NCT03712904 2025-09-24

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Phase 2 Terminated

3 enrolled 9 charts

Dermatologic

Uveal Melanoma

NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 13 charts

Dermatologic

Uveal Melanoma

Clinical Trials

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma